Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Olsson-Brown

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|January 19, 2019
How to get started in quality improvementBryan Jones, Emma Vaux, Anna Olsson-Brown
British Journal of Nursing (Mark Allen Publishing)|September 23, 2024
Enhancing systemic anti-cancer treatment (SACT) capacity: implementing and using subcutaneous atezolizumabAnna Olsson-Brown, Hala Ghoz, Mark Foulkes
Exploration of Targeted Anti-Tumor Therapy|September 16, 2024
Immune checkpoint inhibitor-induced cholangitis-a three-case seriesSimon Gray, Nuria Santamaria, Anna Olsson-Brown
British Journal of Nursing (Mark Allen Publishing)|April 19, 2022
The impact of an immuno-oncology service at a regional cancer centre based in the north west of the UKTrudy-Jane Guinan, Nick Garbutt, Anna Olsson-Brown
Exploration of Targeted Anti-Tumor Therapy|March 11, 2024
A case of immunotherapy-induced thyroiditisGeorge Pears, Abhishek Mahajan, Anna Olsson-Brown, et al.
British Journal of Nursing (Mark Allen Publishing)|May 26, 2017
Using QR codes to enable quick access to information in acute cancer careJoanne Upton, Anna Olsson-Brown, Ernie Marshall, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 26, 2022
Does immune checkpoint inhibitor therapy increase the frequency of adverse reactions to concomitant medications?Sean Hammond, Anna Olsson-Brown, Sophie Grice, et al.
Chemical Research in Toxicology|June 24, 2024
Immunological Drug-Drug Interactions Affect the Efficacy and Safety of Immune Checkpoint Inhibitor TherapiesSophie Grice, Anna Olsson-Brown, Dean J Naisbitt, et al.
BMJ (Clinical Research Ed.)|May 6, 2020
Preventing psychological injury during the covid-19 pandemicMatthew Roycroft, Daniel Wilkes, Simon Fleming, et al.
Occupational Medicine (Oxford, England)|May 20, 2020
Limiting moral injury in healthcare professionals during the COVID-19 pandemicMatthew Roycroft, Daniel Wilkes, Shriti Pattani, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|January 19, 2019
How to get started in quality improvementBryan Jones, Emma Vaux, Anna Olsson-Brown
British Journal of Nursing (Mark Allen Publishing)|September 23, 2024
Enhancing systemic anti-cancer treatment (SACT) capacity: implementing and using subcutaneous atezolizumabAnna Olsson-Brown, Hala Ghoz, Mark Foulkes
Exploration of Targeted Anti-Tumor Therapy|September 16, 2024
Immune checkpoint inhibitor-induced cholangitis-a three-case seriesSimon Gray, Nuria Santamaria, Anna Olsson-Brown
British Journal of Nursing (Mark Allen Publishing)|April 19, 2022
The impact of an immuno-oncology service at a regional cancer centre based in the north west of the UKTrudy-Jane Guinan, Nick Garbutt, Anna Olsson-Brown
Exploration of Targeted Anti-Tumor Therapy|March 11, 2024
A case of immunotherapy-induced thyroiditisGeorge Pears, Abhishek Mahajan, Anna Olsson-Brown, et al.
British Journal of Nursing (Mark Allen Publishing)|May 26, 2017
Using QR codes to enable quick access to information in acute cancer careJoanne Upton, Anna Olsson-Brown, Ernie Marshall, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 26, 2022
Does immune checkpoint inhibitor therapy increase the frequency of adverse reactions to concomitant medications?Sean Hammond, Anna Olsson-Brown, Sophie Grice, et al.
Chemical Research in Toxicology|June 24, 2024
Immunological Drug-Drug Interactions Affect the Efficacy and Safety of Immune Checkpoint Inhibitor TherapiesSophie Grice, Anna Olsson-Brown, Dean J Naisbitt, et al.
BMJ (Clinical Research Ed.)|May 6, 2020
Preventing psychological injury during the covid-19 pandemicMatthew Roycroft, Daniel Wilkes, Simon Fleming, et al.
Occupational Medicine (Oxford, England)|May 20, 2020
Limiting moral injury in healthcare professionals during the COVID-19 pandemicMatthew Roycroft, Daniel Wilkes, Shriti Pattani, et al.
Pageof 4